These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21726543)

  • 1. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes.
    Patwardhan RS; Checker R; Sharma D; Kohli V; Priyadarsini KI; Sandur SK
    Biochem Pharmacol; 2011 Sep; 82(6):642-57. PubMed ID: 21726543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antioxidant/pro-oxidant activity of dimethoxycurcumin, a synthetic analogue of curcumin.
    Kunwar A; Barik A; Sandur SK; Indira Priyadarsini K
    Free Radic Res; 2011 Aug; 45(8):959-65. PubMed ID: 21615275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and its synthetic analogue dimethoxycurcumin differentially modulates antioxidant status of normal human peripheral blood mononuclear cells.
    Simon E; Aswini P; Sameer Kumar VB; Mankadath G
    Free Radic Res; 2018 May; 52(5):583-591. PubMed ID: 29621898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis.
    Kunwar A; Jayakumar S; Srivastava AK; Priyadarsini KI
    Arch Toxicol; 2012 Apr; 86(4):603-14. PubMed ID: 22119759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS.
    Pae HO; Jeong SO; Kim HS; Kim SH; Song YS; Kim SK; Chai KY; Chung HT
    Mol Nutr Food Res; 2008 Sep; 52(9):1082-91. PubMed ID: 18481332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
    Gao X; Kuo J; Jiang H; Deeb D; Liu Y; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
    Biochem Pharmacol; 2004 Jul; 68(1):51-61. PubMed ID: 15183117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
    Teymouri M; Barati N; Pirro M; Sahebkar A
    J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.
    Hertenstein A; Schumacher T; Litzenburger U; Opitz CA; Falk CS; Serafini T; Wick W; Platten M
    Biochem Pharmacol; 2011 Sep; 82(6):632-41. PubMed ID: 21703247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin.
    Tamvakopoulos C; Dimas K; Sofianos ZD; Hatziantoniou S; Han Z; Liu ZL; Wyche JH; Pantazis P
    Clin Cancer Res; 2007 Feb; 13(4):1269-77. PubMed ID: 17317839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
    Moon DO; Kim MO; Choi YH; Park YM; Kim GY
    Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.
    Ranjan D; Chen C; Johnston TD; Jeon H; Nagabhushan M
    J Surg Res; 2004 Oct; 121(2):171-7. PubMed ID: 15501456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia.
    Jin CY; Lee JD; Park C; Choi YH; Kim GY
    Acta Pharmacol Sin; 2007 Oct; 28(10):1645-51. PubMed ID: 17883952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages.
    Kang BY; Song YJ; Kim KM; Choe YK; Hwang SY; Kim TS
    Br J Pharmacol; 1999 Sep; 128(2):380-4. PubMed ID: 10510448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes encapsulated dimethyl curcumin regulates dipeptidyl peptidase I activity, gelatinase release and cell cycle of spleen lymphocytes in-vivo to attenuate collagen induced arthritis in rats.
    Sun Z; Wei T; Zhou X
    Int Immunopharmacol; 2018 Dec; 65():511-521. PubMed ID: 30408628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to novel allergens and modulation of inflammation by vitamin K3 analogue: a ROS dependent mechanism.
    Kohli V; Sharma D; Sandur SK; Suryavanshi S; Sainis KB
    Int Immunopharmacol; 2011 Feb; 11(2):233-43. PubMed ID: 21134493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of a curcumin analogue dimethoxycurcumin with DNA.
    Kunwar A; Simon E; Singh U; Chittela RK; Sharma D; Sandur SK; Priyadarsini IK
    Chem Biol Drug Des; 2011 Apr; 77(4):281-7. PubMed ID: 21244640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.
    Dahlén R; Strid H; Lundgren A; Isaksson S; Raghavan S; Magnusson MK; Simrén M; Sjövall H; Öhman L
    Scand J Immunol; 2013 Sep; 78(3):275-84. PubMed ID: 23713660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.